Fermer le menu


Member of Lyonbiopole


Promise Proteomics is a medtech company, based in France and funded in 2010.

We are a fully integrated company dedicated to innovation, development, manufacturing and registration of CE-IVD solutions.

Our main area of work:

- developing early diagnostics kits for biodefense

- developing ready-to-use kits for monitoring monoclonal antibodies (mAbXmise range of products).

Our solutions are designed to be adapted for the clinical lab.

Our solutions are combining our specific expertise: quantitative LC-MS technology and the use of stable labelled proteins as internal standards.

Nearby, Promise continues to innovate to develop tailored solutions for diagnostics.

Promise Proteomics is also providing its customers with a range of stable-labelled proteins for bioanalysis, available off the shelf or custom.


Strategic application domain: Human Medicine

Application market: Immune, AutoIm & Inflam. diseases, Neurology & Mental Health Disorders, Oncology

Type of activity: Diagnostics, Technology provider

Technologies: Analytical methods, diagnostic & Pronostic markers, Antibodies - Protein - Peptide

Created on nov. 14th, 2000 - 23 employees



7, Parvis Louis Néel BHT-52A CS 20050 38040 Grenoble



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.